Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2323-2025

HemosIL LMW Heparin Controls; Part Number: 0020300200; Recall

HemosIL LMW Heparin Controls; Part Number: 0020300200;

FDA recall Class II

Ongoing

FDA lists this Class II recall for HemosIL LMW Heparin Controls; Part Number: 0020300200;. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2323-2025
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Feb 3, 2025
FDA report date
Aug 20, 2025
Quantity in commerce
41,824 units
Distribution
See key details
FDA cause
Process control

What is being recalled?

HemosIL LMW Heparin Controls; Part Number: 0020300200;

Affected model & UDI checker

Search the exact identifiers published for Z-2323-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
Not specifiedHemosIL LMW Heparin Controls; Part Number: 0020300200;Check source notice08426950472490
FDA code information

Part Number: 0020300200; UDI-DI: 08426950472490; Lot Numbers: N0330228, N0632773, N0935135, N1036592, N0148986, N0441476, N0643673, N0845161, N1147397;

View the original FDA recall notice

Why was this product recalled?

Multiple complaints indicating lower than expected quality control (QC) results and in some instances QC recovery below the lower limit of the package insert acceptance range when testing is performed with HemosIL Liquid Anti-Xa and HemosIL Heparin Calibrator. In some complaints, failure to pass QC resulted in patient testing delays.

What actions did Instrumentation Laboratory take?

On February 3, 2025, URGENT MEDICAL DEVICE CORRECTION letters were sent to customers. Requested Customer Actions Please take the following actions: " Follow the instructions in the original Urgent Medical Device Correction letter to update the ACL TOP test parameters with the corrected value assignments for HemosIL Heparin Calibrators (Part No. 0020300600). " For HemosIL UF Heparin Controls (Part No. 0020300300), continue to use the current target values and acceptance ranges as labeled. " For HemosIL LMW Heparin Controls (Part No. 0020300200), use the reassigned target values and acceptance ranges for the Low and High Controls as provided in the table above. " Note: if the 2D Barcode is scanned, customers need to manually override the uploaded values with those provided in this letter. " Follow the instructions below to update the Quality Control Material Definitions with the updated values (same instructions for all Instrument models): " Select Setup from the menu bar and then select Material List from the dropdown menu. " From Material List , double click on the Material Name LMW Hep Low Control and LMW Hep High Control (performed separately) to open Material Definition . " From Material Definition LMW Hep Low Control or LMW Hep High Control , click on Assigned Values icon (picture of bullseye) under the header. An editable table titled Assigned Values for IL Material Definition Quality Control LMW Hep Low Control or LMW Hep High Control will appear with the Anti-Xa Test Code, Active Lot, and Alternative Lot (if applicable). " In the Assigned Values table, select the Active and/or Alternative lot, and change the target values for LMW Hep Low Control and LMW Hep High Control to the reassigned values provided in the table. " After entering the reassigned values for LMW Hep Low Control and LMW Hep High Control , click on OK to save the changes. " Run quality controls per labeled instructions for use. New acceptance ranges for HemosIL L

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology